CLinical Assessment of WEB device in Ruptured aneurYSms (CLARYS): results of 1-month and 1-year assessment of rebleeding protection and clinical safety in a multicenter study - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Journal of Neurointerventional Surgery Year : 2021

CLinical Assessment of WEB device in Ruptured aneurYSms (CLARYS): results of 1-month and 1-year assessment of rebleeding protection and clinical safety in a multicenter study

Jean-Yves Gauvrit
Hubert Desal

Abstract

Background The primary goal of the CLARYS study is to assess the protection against rebleeding when treating ruptured bifurcation aneurysms with the Woven EndoBridge (WEB) device. Methods The CLARYS study is a prospective, multicenter study conducted in 13 European centers. Patients with ruptured bifurcation aneurysms were consecutively included between February 2016 and September 2017. The primary endpoint was defined as the rebleeding rate of the target aneurysm treated with the WEB within 30 days postprocedure. Secondary endpoints included periprocedural and postprocedural adverse events, total procedure and fluoroscopy times, and modified Rankin Scale score at 1 month and 1 year. Results Sixty patients with 60 ruptured bifurcation aneurysms to be treated with the WEB were included. A WEB device was successfully implanted in 93.3%. The rebleeding rate at 1 month and 1 year was 0%. The mean fluoroscopy time was 27.0 min. Twenty-three periprocedural complications were observed in 18 patients and resolved without sequelae in 16 patients. Two of these complications were attributed to the procedure and/or the use of the WEB, leading to a procedure/device-related intraoperative complication rate of 3.3%. Overall mortality at 1 month and 1 year was 1.7% and 3.8%, respectively and overall morbidity at 1 month and 1 year was 15% and 9.6%, respectively. WEB-related 1-month and 1-year morbidity and mortality was 0%. Conclusions The interim results of CLARYS show that the endovascular treatment of ruptured bifurcation aneurysms with the WEB is safe and effective and, in particular, provides effective protection against rebleeding. It may induce profound change in the endovascular management of ruptured bifurcation aneurysms.

Domains

Imaging
Fichier principal
Vignette du fichier
neurintsurg-2021-017416.full.pdf (535.68 Ko) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

inserm-03482251 , version 1 (15-12-2021)

Identifiers

Cite

Laurent Spelle, Denis Herbreteau, Jildaz Caroff, Xavier Barreau, Jean-Christophe Ferré, et al.. CLinical Assessment of WEB device in Ruptured aneurYSms (CLARYS): results of 1-month and 1-year assessment of rebleeding protection and clinical safety in a multicenter study. Journal of Neurointerventional Surgery, 2021, pp.neurintsurg-2021-017416. ⟨10.1136/neurintsurg-2021-017416⟩. ⟨inserm-03482251⟩
37 View
42 Download

Altmetric

Share

Gmail Facebook X LinkedIn More